Generation and preclinical characterization of a novel bispecific CD19-TCRgammadelta antibody for the treatment of B cell acute lymphoblastic leukemia

IntroductionB-cell acute lymphoblastic leukemia (B-ALL) is characterized by the clonal expansion of immature lymphoblastic cells. Treating patients with disease relapse is challenging, especially after allogeneic stem cell transplantation (aSCT). Although the CD19xCD3 bispecific antibody (bsAb) blin...

Descripció completa

Dades bibliogràfiques

Autors principals:	Joseph Kauer, Fabian Vogt, Sebastian Hörner, Valentin Schmidt, Carsten Müller-Tidow, Simon Raffel, Helmut R. Salih, Gundram Jung, Martin Pflügler
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2026-02-01
Col·lecció:	Frontiers in Immunology
Matèries:	acute lymphoblastic leukemia bispecific antibodies CD19 gammadelta T cells immunotherapy
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1728424/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!